Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers

RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past two decades. RNAi-based therapeutics including siRNA and shRNA have immense scope to silence the expression of mutant cancer genes specifically in a therapeutic context. Although tremendous progress ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Karim, Md. Emranul, Tha, Kyi Kyi, Othman, Iekhsan, Borhan Uddin, Mohammad, Chowdhury, Ezharul Hoque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026921/
https://www.ncbi.nlm.nih.gov/pubmed/29861465
http://dx.doi.org/10.3390/pharmaceutics10020065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026921/
https://www.ncbi.nlm.nih.gov/pubmed/29861465
http://dx.doi.org/10.3390/pharmaceutics10020065

Ejemplares similares